Hopper, Ingrid

A/Prof Ingrid Hopper

Heart Failure Physician; Clinical Pharmacologist; Alfred Hospital; NHMRC Fellow, Head of Drug and Device Registries, School of Public Health and Preventive Medicine, Monash University
A/Prof Ingrid Hopper is a heart failure physician and clinical pharmacologist.

A/Prof Hopper completed her physician training at Alfred Hospital and then a PhD in heart failure therapeutics, specifically medication withdrawal in patients with polypharmacy. She was awarded the Mollie Holman medal for best thesis in the Monash University Faculty of Medicine, Nursing and Health Sciences, and was a finalist in the Victorian Premier’s Prize for Health and Medical Research. Her research formed a practice recommendation in the Australian Heart Failure guidelines 2018.

At the Alfred, she consults in Heart Failure Clinic, and is an investigator on a number of clinical trials. She is a NHMRC early career fellow, and head of drug and device registries at the School of Public Health and Preventive Medicine, Monash University. Her interests include the safe and effective use of medications and high risk implantable medical devices, quality improvement in healthcare including through clinical quality registries, epidemiology and public health. She has over 50 peer reviewed publications.

More from this expert

Podcasts iconPodcasts

A/Prof Ingrid Hopper, a Heart Failure Physician and Clinical Pharmacologist, discusses the epidemiology of heart failure in Australia, including the differentiation between and management of HFrEF vs HFpEF.

A/Prof Ingrid Hopper, a Heart Failure Physician and Clinical Pharmacologist, discusses the epidemiology of heart failure in Australia, including the differentiation between and management of HFrEF vs HFpEF.

Podcasts iconPodcasts

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.